Helen Kim

Member Board of Directors at IconOVir Bio in December 2020 to Present

Member Board of Directors at Aktis Oncology in February 2021 to Present

Member Board of Directors at Protego Biopharma in October 2021 to Present

Member Board of Directors at InduPro in February 2022 to Present

Member Board of Directors at Prothena Corporation plc in August 2022 to Present

Board Member at Applied Molecular Transport in October 2018 to April 2022

Member Board Of Directors at Assembly Biosciences, Inc. in March 2018 to December 2020

Board Member at Exicure in January 2014 to November 2020

Partner at The Column Group in March 2018 to March 2019

Executive Vice President at Kite Pharma, Inc. in June 2014 to January 2018

Board Member at Forsight Vision 4 in January 2012 to January 2017

Board Director at Sunesis Pharmaceuticals in July 2009 to February 2016

Strategic Advisor formerly Chief Business Officer at NGM Biopharmaceuticals, Inc. in August 2009 to November 2014

Board member at ImmunoCellular Therapeutics Ltd in August 2011 to September 2014

Board director at West Coast Clinical Trials, Global in October 2011 to January 2012

Board member at Trinity Biosystems in July 2009 to May 2010

President and CEO at Kosan Biosciences in January 2007 to January 2008

Chief Program Officer at Gordon and Betty Moore Foundation in January 2003 to January 2007

Chief Business Officer at Affymax in January 2002 to January 2003

Sr. Vice President, Corporate Development at Onyx Pharmaceuticals Inc. in January 1999 to January 2002

Vice President, Marketing and Product Development at PDL Pharma in July 1998 to December 1999

Vice President, Marketing & Business Development at Chiron in January 1989 to January 1998